Highly thermostable DNA ligase for applications where ligation at high temperature is beneficial
- High thermostability allows ligation using high-stringency hybridization conditions
- High specificity and stringency permits sensitive detection of SNPs11
- Ligation amplification (Ligase Chain Reaction, LCR)1-7
- Repeat Expansion Detection (RED)7
- Simultaneous mutagenesis of multiple sites8,9
- Other ligation-based detection methods
Ampligase® Thermostable DNA Ligase catalyzes NAD-dependent ligation of adjacent 3´-hydroxylated and 5´-phosphorylated termini in duplex DNA structures that are stable at high temperatures. Derived from a thermophilic bacterium, the enzyme is stable and active at much higher temperatures than conventional DNA ligases. Its half-life is 48 hours at 65°C and greater than 1 hour at 95°C. Ampligase DNA Ligase has been shown to be active for at least 500 thermal cycles (94°C/80°C) or 16 hours of cycling.10 This exceptional thermostability permits extremely high hybridization stringency and ligation specificity. Ampligase DNA Ligase has no detectable activity in ligating blunt-ended DNA and has no activity on RNA or RNA:DNA hybrids.
Unit Definition: One unit of Ampligase DNA Ligase catalyzes the ligation of 50% of the cos sites in 1 µg of lambda DNA in 1 minute at 45°C in 1X Ampligase Reaction Buffer.
Note: One unit of Ampligase DNA Ligase is equivalent to at least 15 of the "cohesive end units" or "nick ligation units" defined elsewhere.4
Storage Buffer: 50% glycerol containing 50 mM Tris-HCl (pH 7.5), 0.1 M NaCl, 0.1 mM EDTA, 1 mM DTT, and 0.1% Triton® X-100.
Ampligase 10X Reaction Buffer: 200 mM Tris-HCl (pH 8.3), 250 mM KCl, 100 mM MgCl2, 5 mM NAD, and 0.1% Triton® X-100.
Quality Control: Ampligase Thermostable DNA Ligase is assayed for the absence of blunt-end ligation activity by ligating Sma I-digested bacteriophage lambda DNA at 45°C; ligation occurs only at cos sites as determined by gel electrophoresis. Ampligase DNA Ligase is free of detectable exo- and endonuclease and RNase activities.
- Landegren, U. et al. (1988) Science 242, 229.
- Wu, D.Y. and Wallace, R.B. (1989) Genomics 4, 560.
- Barany, F. (1991) Proc. Natl. Acad. Sci. USA 88, 189.
- Birkenmeyer, L. and Armstrong, A.S. (1992) J. Clin. Micro. 30, 3089.
- Dille, B.J. et al. (1993) J. Clin. Micro. 31, 729
- Nakazawa, H. et al. (1994) Proc. Natl. Acad. Sci. USA 91, 360.
- Sirugo, G. and Kidd, K. (1995) Epicentre Forum 2(3), 1.
- Moore, D. and Michael, S. (1995) Epicentre Forum 2(4), 4.
- Rouwendal, G.J. et al. (1993) BioTechniques 15, 68.
- Schalling, M. et al. (1993) Nature Genetics 4, 135.
- Hardenbol, P. et al. (2003) Nature Biotechnology 21, 673.